1. Platz-Christensen JJ, Sundström E, Larsson PG. Bacterial vaginosis and cervical intraepithelial neoplasia. Acta Obstet Gynecol Scand. 1994. 73:586–588.
2. Peters N, Van Leeuwen AM, Pieters WJ, Hollema H, Quint WG, Burger MP. Bacterial vaginosis is not important in the etiology of cervical neoplasia: a survey on women with dyskaryotic smears. Sex Transm Dis. 1995. 22:296–302.
3. Pavić N. Is there a local production of nitrosamines by the vaginal microflora in anaerobic vaginosis/trichomoniasis? Med Hypotheses. 1984. 15:433–436.
4. McNicol PJ, Paraskevas M, Guijon FB. The effect of vaginal microbes on in vivo and in vitro expression of human papillomavirus 16 E6-E7 genes. Cancer Detect Prev. 1999. 23:13–21.
5. Lehmann F, Marchand M, Hainaut P, Pouillart P, Sastre X, Ikeda H, et al. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur J Immunol. 1995. 25:340–347.
6. Sheu BC, Hsu SM, Ho HN, Lin RH, Torng PL, Huang SC. Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma. Cancer. 1999. 86:1537–1543.
7. Tsukui T, Hildesheim A, Schiffman MH, Lucci J 3rd, Contois D, Lawler P, et al. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res. 1996. 56:3967–3974.
8. de Gruijl TD, Bontkes HJ, Stukart MJ, Walboomers JM, Remmink AJ, Verheijen RH, et al. T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection. J Gen Virol. 1996. 77:2183–2191.
9. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001. 357:1191–1194.
10. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991. 29:297–301.
11. Boyle DC, Barton SE, Uthayakumar S, Hay PE, Pollock JW, Steer PJ, et al. Is bacterial vaginosis associated with cervical intraepithelial neoplasia? Int J Gynecol Cancer. 2003. 13:159–163.
12. Castle PE, Hillier SL, Rabe LK, Hildesheim A, Herrero R, Bratti MC, et al. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev. 2001. 10:1021–1027.
13. Laurence J. Repetitive and consistent cervicovaginal exposure to certain viral pathogens appears to protect against their sexual acquisition in some women: potential mechanisms. J Reprod Immunol. 2003. 58:79–91.
14. Briselden AM, Moncla BJ, Stevens CE, Hillier SL. Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora. J Clin Microbiol. 1992. 30:663–666.
15. Gillet E, Meys JF, Verstraelen H, Bosire C, De Sutter P, Temmerman M, et al. Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis. BMC Infect Dis. 2011. 11:10.
16. Cauci S. Vaginal Immunity in Bacterial Vaginosis. Curr Infect Dis Rep. 2004. 6:450–456.
17. Figueiredo PG, Sarian LO, Tambascia JK, Simões JA, Rabelo-Santos SH, Discacciati MG, et al. Increased detection of clue cells in smears from cervical intraepithelial lesions with reduced expression of COX-2. Diagn Cytopathol. 2008. 36:705–709.
18. Mao C, Hughes JP, Kiviat N, Kuypers J, Lee SK, Adam DE, et al. Clinical findings among young women with genital human papillomavirus infection. Am J Obstet Gynecol. 2003. 188:677–684.
19. Kjaer SK, Svare EI, Worm AM, Walboomers JM, Meijer CJ, van den Brule AJ. Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis. 2000. 27:438–445.
20. Nunn CL, Gittleman JL, Antonovics J. Promiscuity and the primate immune system. Science. 2000. 290:1168–1170.